Evaluating the Sensory Index for Success of Trigeminal RF

Status Completed

Clinical Trial Summary

Clinical Trial Description

Trigeminal neuralgia (TN) is defined by the International Headache Society (IHS) as "unilateral disorder characterized by brief electric shock-like pains, abrupt in onset and termination, and limited to the distribution of one or more divisions of the trigeminal nerve" . It is considered the worst type of facial pain and described as intense, sharp, stabbing, and shooting like electric shock pain. It can be triggered by touch, chewing, laughing, shaving or face wash. The IHS suggests a classification of TN as either classic (essential or idiopathic) TN (CTN) or symptomatic TN (STN; pain indistinguishable from that of CTN, but caused by a demonstrable structural lesion other than vascular compression). Treatment of TN is conservative, surgical or interventional. Pharmacotherapy with carbamazepine is tried early in cases of TN but has many side effects .Other medications can be used in the treatment of TN, include oxycarbazepine, gabapentin, pregabalin, baclofen, valproate, clonazepam, phenytoin, and lamotrigime . The most clinically appropriate treatment includes surgical microvascular decompression (MVD), stereotactic radiation therapy, gamma knife (SGK), percutaneous balloon decompression, percutaneous glycerol rhizolysis, percutaneous radiofrequency (RF) of the Gasserian ganglion (GG), and GG stimulation and neuromodulation . Interventional therapies for TN are of variable efficacy and safety, and have different results for different periods of time before the recurrence of symptoms. Interventional therapy for TN is either destructive with trigeminal nerve sensory function destroyed intentionally or non-destructive with decompression of the trigeminalnerve and preservation of its regular function. The most common procedures in treating TN pain are the use of radiofrequency (RF) . Radiofrequency thermos-coagulation of the GG is thought to selectively destroy the pain fibers by thermos-coagulation at > 65°C , that helps reduce pain and prevent triggering, but can cause bothersome dysesthesia . Another method, pulsed radiofrequency (PRF) which defined as the delivery of short pulses of RF via a needle tip, thereby a short exposure at the same temperature will result in less thermal tissue destruction . Combined conventional and pulsed radiofrequency (CCPRF) achieved comparable pain relief to PRF treatment alone in patients with chronic pain, the combination of PRF and CRF would increase the effect of CRF and reduce the need for long-duration CRF (LCRF) and its attendant side effects . ;

Study Design

Related Conditions & MeSH terms

Radiotherapy; Complications

Clinical Trial Details

NCT number	NCT05748132
Study type	Interventional
Source	National Cancer Institute, Egypt
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2014
Completion date	March 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05059379` - Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer	Phase 3
Recruiting	`NCT06197581` - Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer	N/A
Recruiting	`NCT06042946` - Microsurgical Resection of Intramedullary Spinal Cord Metastases
Completed	`NCT04321187` - Influence of Prostate Cancer Radiation on Aging
Terminated	`NCT03553212` - Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy	N/A
Completed	`NCT02979691` - Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01	Phase 2/Phase 3
Terminated	`NCT03720158` - Enteral Omega 3 During Radiotherapy to Improve the Quality of Life and Functionality of Head and Neck Cancer Patients	N/A
Not yet recruiting	`NCT05339581` - IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation	N/A
Recruiting	`NCT05308732` - Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy	Phase 1
Recruiting	`NCT06313450` - De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma	N/A
Active, not recruiting	`NCT03893461` - Coagulation System In STereotactic Radiotherapy Of NSCLC
Active, not recruiting	`NCT03475186` - Testing Ramipril to Prevent Memory Loss in People With Glioblastoma	Phase 2
Recruiting	`NCT04819685` - Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury	Phase 4
Completed	`NCT04854525` - Breast Reconstruction in Previously Irradiated Breast
Completed	`NCT04783818` - Adjuvant Radiotherapy's Effect on One and Two Stages Prosthetic Breast Reconstruction and on Autologous Reconstruction
Completed	`NCT03226925` - Mechanically-assisted Ventilation in the Treatment of Moving Tumours With Photon and Proton Therapies	N/A
Recruiting	`NCT04901234` - Adaptive RadioTherapy for OroPharynx Cancer	Phase 2
Recruiting	`NCT06272617` - Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer	N/A
Not yet recruiting	`NCT05561634` - Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma	Phase 2
Not yet recruiting	`NCT03168048` - Oncologic Therapy Support Via Means of a Dedicated Mobile App	N/A